Skip to main content
. 2022 Jun 22;9:927092. doi: 10.3389/fnut.2022.927092

Figure 1.

Figure 1

Links between obesity, COVID-19 and statins. Obesity increased the risks of adverse COVID-19 outcomes, and dyslipidemia is a major link between obesity and COVID-19 severity. Statins may benefit COVID-19 patients, especially those with obesity and dyslipidemia, due to their multiple effects.